Potent and selective CCR5 antagonist with strong anti-HIV activity. Prevents HIV-1 gp120 binding to CCR5, preventing cell-cell fusion. Inhibited MIP-1a (IC50 = 3.3 nM), MIP-1b (IC50 = 7.2 nM), and RANTES (IC50 = 5.2 nM) binding to CCR5-expressing HEK-293 cells. Clinically useful antiretroviral...
Know who made it. See the evidence. Buy through one marketplace.
Potent and selective CCR5 antagonist with strong anti-HIV activity. Prevents HIV-1 gp120 binding to CCR5, preventing cell-cell fusion. Inhibited MIP-1a (IC50 = 3.3 nM), MIP-1b (IC50 = 7.2 nM), and RANTES (IC50 = 5.2 nM) binding to CCR5-expressing HEK-293 cells. Clinically useful antiretroviral drug. Many cancer cells express CCR5: Maraviroc blocks metastasis of basal breast and pancreatic cancer cells, induces cytotoxic and apoptotic effects in colorectal cancer cells, reduces metastatic tumor growth in lungs, and suppresses growth in acute ALL cells. CCR inhibition with maraviroc induces macrophage repolarization with anti-tumoral effects
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
CCR5 identifies C-C motif chemokine receptor 5 in Homo sapiens (Human). This target record connects NCBI Gene 1234, UniProtKB P51681 and related ABMIUM catalogue products.
